Avoidance of Cardiopulmonary Bypass Improves Early Survival in Multivessel Coronary Artery Bypass Patients with Poor

Todd M Dewey1, Morley A. Herbert, Syma L. Prince

  • 1Cardiopulmonary Research Science and Technology Institute, Dallas, Texas.

The Heart Surgery Forum
|February 26, 2004
PubMed

Insights

Off-pump coronary artery bypass grafting (CABG) in patients with reduced ventricular function significantly lowers mortality and complications. Avoiding cardiopulmonary bypass (CPB) improves outcomes for this high-risk group undergoing multivessel bypass.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes

Background:

  • Coronary artery bypass grafting (CABG) is increasingly performed in patients with diminished ventricular function (ejection fraction ≤30%).
  • This patient group represents a high-risk population for CABG procedures.

Purpose of the Study:

  • To identify factors influencing outcomes in high-risk patients undergoing CABG with ejection fractions (EF) ≤30%.
  • To compare outcomes between off-pump and on-pump CABG in patients with severely reduced ventricular function.

Main Methods:

  • Retrospective analysis of 990 patients with EF ≤30% who underwent CABG between January 1997 and September 2002.
  • Comparison of 204 off-pump CABG patients versus 713 on-pump CABG patients using univariate and logistic regression analysis.
  • Evaluation of differences in mortality, morbidity, and length of stay (LOS).

Main Results:

  • Off-pump CABG patients showed a trend toward lower operative mortality (2.9% vs. 6.3%, P=.06) and significantly lower risk-adjusted mortality (1.47% vs. 4.13%, P<.001).
  • Off-pump CABG was associated with significantly lower reoperation for bleeding (1.0% vs. 4.6%, P=.02), reduced blood product use (39.6% vs. 66.6%, P<.001), shorter ventilation times, and fewer ICU days.
  • Cardiopulmonary bypass (CPB) use (OR 2.4) and prior CABG (OR 2.6) were independent risk factors for mortality.

Conclusions:

  • Avoiding CPB in patients with reduced ventricular function undergoing multivessel bypass surgery improves early survival.
  • Off-pump CABG significantly decreases the incidence of reoperation for bleeding, blood product usage, and postoperative ventilation duration in this high-risk cohort.
  • The findings support the use of off-pump techniques to enhance outcomes for patients with severely impaired ventricular function undergoing CABG.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...